GlassScriptPhysician profile
Stephen James Rohrer
NPI 1821205873
$313.29
in general payments reported to CMS, 2019-2025
10 companies · $18.59 in 2025
The $18.59 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.45 · 2021: $42.98 · 2023: $59.55 · 2024: $118 · 2025: $18.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $85.67 | 2019-2024 | Orthovisc |
| Edwards Lifesciences Corporation | $51.96 | 2024 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $38.46 | 2021-2023 | |
| Seqirus USA INC | $24.72 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Glaxosmithkline, LLC. | $20.67 | 2021 | |
| Phadia US INC. | $20.58 | 2024 | Immunocap |
| Baxter Healthcare | $20.04 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $18.68 | 2023 | |
| Hologic Sales and Service, LLC | $18.59 | 2025 | Aptima |
| Teva Pharmaceuticals USA, INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rohrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.